Alembic Pharma Gets USFDA Approval for Ivosidenib Tablets
July 4, 2024 15:00
Alembic Pharmaceuticals receives tentative USFDA approval for its generic Ivosidenib tablets, a treatment for certain types of cancer of bone marrow and bile duct. The drug is therapeutically...